Trademark: 90273158
Word
PLATELETBIO
Status
Dead
Status Code
602
Status Date
Monday, June 5, 2023
Serial Number
90273158
Mark Type
3000
Filing Date
Friday, October 23, 2020
Abandoned Date
Monday, April 17, 2023

Trademark Owner History

Classifications
5 Platelets that are not bone marrow-derived, platelet variants, megakaryocytes, megakaryocytes variants, and products derived from platelets, megakaryocytes or their variants, and admixtures, namely, extracellular vesicles or exosomes, all the foregoing for medical or clinical use; platelet variants for medical or clinical use; pharmaceutical and drug delivery compositions comprising platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; Pharmaceutical compositions for drug delivery comprising non bone marrow-derived platelets, platelet variants for treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; pharmaceutical compositions comprising platelet variants for transfusion in oncology, trauma and surgery; platelet variants for delivering proteins, antibodies, nucleic acids and other drugs to tumors, sites of vascular injury and inflammation, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders, and orthopedics; platelet variants as source for growth factors for medical or clinical use; compositions comprising viral vectors for medical or clinical use
The mark consists of the word PLATELETBIO to the left of a Pegasus design.
PLATELET BIO

Trademark Events
Jun 6, 2023
Abandonment Notice E-Mailed - Failure To Respond
Jun 5, 2023
Abandonment Notice Mailed - Failure To Respond
Jun 5, 2023
Abandonment - Failure To Respond Or Late Response
Oct 15, 2022
Notification Of Non-Final Action E-Mailed
Oct 15, 2022
Non-Final Action E-Mailed
Oct 15, 2022
Non-Final Action Written
Apr 13, 2022
Teas/Email Correspondence Entered
Apr 13, 2022
Correspondence Received In Law Office
Apr 12, 2022
Assigned To Lie
Apr 7, 2022
Assigned To Lie
Apr 6, 2022
Teas Voluntary Amendment Received
Oct 9, 2021
Teas/Email Correspondence Entered
Oct 8, 2021
Correspondence Received In Law Office
Oct 8, 2021
Teas Response To Office Action Received
Apr 8, 2021
Notification Of Non-Final Action E-Mailed
Apr 8, 2021
Non-Final Action E-Mailed
Apr 8, 2021
Non-Final Action Written
Mar 24, 2021
Assigned To Examiner
Dec 12, 2020
Notice Of Design Search Code E-Mailed
Dec 11, 2020
New Application Office Supplied Data Entered
Oct 27, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24